Cargando…
Formulation and evaluation of periodontal in situ gel
BACKGROUND: The present study was aimed to develop and optimize in situ gel for the treatment of periodontal disease. MATERIALS AND METHODS: Temperature-sensitive in situ gel containing 0.1% w/v Chlorhexidine hydrochloride was formulated by cold method using different polymers. Preliminary study was...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687234/ https://www.ncbi.nlm.nih.gov/pubmed/23799203 http://dx.doi.org/10.4103/2230-973X.108961 |
_version_ | 1782273884287926272 |
---|---|
author | Garala, Kevin Joshi, Parth Shah, Malay Ramkishan, A Patel, Jaydeep |
author_facet | Garala, Kevin Joshi, Parth Shah, Malay Ramkishan, A Patel, Jaydeep |
author_sort | Garala, Kevin |
collection | PubMed |
description | BACKGROUND: The present study was aimed to develop and optimize in situ gel for the treatment of periodontal disease. MATERIALS AND METHODS: Temperature-sensitive in situ gel containing 0.1% w/v Chlorhexidine hydrochloride was formulated by cold method using different polymers. Preliminary study was carried out to optimize different types and concentration of polymers such as Poloxamer 188, Poloxamer 407, Gellan gum, and Carbopol 934P. Central composite design was employed for optimization of the effect of independent variables such as Poloxamer 407 and Carbopol 934P on responses such as gelation temperature, spreadability, cumulative percentage release at 2 h, and time for 50% drug release (t(50) %). Each formulations were evaluated for clarity, pH, gelation temperature, spreadability, drug content, in vitro drug release, t(50) %, and cumulative percentage drug release at 2 h. RESULTS: Results of evaluation parameters revealed that the drug release, gelation temperature was considerably decreased with increasing t(50) % as the concentration of each polymer was increased. The desirability function was utilized to find out optimized formulation of the factorial design. Formulation F6 showed the highest overall desirability of 0.6283 and, therefore, this formulation was considered to be the optimized formulation. The % relative error was calculated, which showed that observed responses were in close agreement with the predicted values calculated from the generated regression equations. CONCLUSION: The clarity, pH, drug content of all formulations was found to be satisfactory. Further, all the formulations showed sustained drug release for a period of 6 h, which satisfied to treat periodontal disease. |
format | Online Article Text |
id | pubmed-3687234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36872342013-06-24 Formulation and evaluation of periodontal in situ gel Garala, Kevin Joshi, Parth Shah, Malay Ramkishan, A Patel, Jaydeep Int J Pharm Investig Original Research Article BACKGROUND: The present study was aimed to develop and optimize in situ gel for the treatment of periodontal disease. MATERIALS AND METHODS: Temperature-sensitive in situ gel containing 0.1% w/v Chlorhexidine hydrochloride was formulated by cold method using different polymers. Preliminary study was carried out to optimize different types and concentration of polymers such as Poloxamer 188, Poloxamer 407, Gellan gum, and Carbopol 934P. Central composite design was employed for optimization of the effect of independent variables such as Poloxamer 407 and Carbopol 934P on responses such as gelation temperature, spreadability, cumulative percentage release at 2 h, and time for 50% drug release (t(50) %). Each formulations were evaluated for clarity, pH, gelation temperature, spreadability, drug content, in vitro drug release, t(50) %, and cumulative percentage drug release at 2 h. RESULTS: Results of evaluation parameters revealed that the drug release, gelation temperature was considerably decreased with increasing t(50) % as the concentration of each polymer was increased. The desirability function was utilized to find out optimized formulation of the factorial design. Formulation F6 showed the highest overall desirability of 0.6283 and, therefore, this formulation was considered to be the optimized formulation. The % relative error was calculated, which showed that observed responses were in close agreement with the predicted values calculated from the generated regression equations. CONCLUSION: The clarity, pH, drug content of all formulations was found to be satisfactory. Further, all the formulations showed sustained drug release for a period of 6 h, which satisfied to treat periodontal disease. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3687234/ /pubmed/23799203 http://dx.doi.org/10.4103/2230-973X.108961 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Garala, Kevin Joshi, Parth Shah, Malay Ramkishan, A Patel, Jaydeep Formulation and evaluation of periodontal in situ gel |
title | Formulation and evaluation of periodontal in situ gel |
title_full | Formulation and evaluation of periodontal in situ gel |
title_fullStr | Formulation and evaluation of periodontal in situ gel |
title_full_unstemmed | Formulation and evaluation of periodontal in situ gel |
title_short | Formulation and evaluation of periodontal in situ gel |
title_sort | formulation and evaluation of periodontal in situ gel |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687234/ https://www.ncbi.nlm.nih.gov/pubmed/23799203 http://dx.doi.org/10.4103/2230-973X.108961 |
work_keys_str_mv | AT garalakevin formulationandevaluationofperiodontalinsitugel AT joshiparth formulationandevaluationofperiodontalinsitugel AT shahmalay formulationandevaluationofperiodontalinsitugel AT ramkishana formulationandevaluationofperiodontalinsitugel AT pateljaydeep formulationandevaluationofperiodontalinsitugel |